1. Home
  2. News
  3. Zhejiang Chengyi Pharmaceutical Co. Ltd.
  4. Announcement on Outline of the Q3 2024 Performance Briefing
More Zhejiang Chengyi Pharmaceutical Co. Ltd. news
Zhejiang Chengyi Pharmaceutical Co. Ltd.SSE: 603811

Announcement on Outline of the Q3 2024 Performance Briefing

Nov 19, 2024 · Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 19, 2024 · 4 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-outline-of-the-q3-2024-performance-briefing-45

Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix

Earlier from Zhejiang Chengyi Pharmaceutical

  • Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Nov 14, 2024
  • Announcement on Obtaining Share Repurchase Loans from Financial InstitutionsNov 8, 2024
  • Report for Q3 2024Oct 29, 2024

Later from Zhejiang Chengyi Pharmaceutical

  • Announcement on Progress in Repurchasing 2% of Shares through Call AuctionDec 24, 2024
  • Announcement on the Acquisition of Drug Registration Certificate for Calcitriol Soft CapsulesJan 3, 2025
  • Announcement on Obtaining Australia's TGA-GMP CertificateJan 11, 2025
  • Announcement on the Acquisition of Drug Registration Certificate for Mercaptopurine TabletsApr 15, 2025
  • Report for Q1 2025Apr 30, 2025
All Zhejiang Chengyi Pharmaceutical news releases↗

Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang Chengyi Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer